Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Becton Dickinson (NY:BDX)

205.44 -4.58 (-2.18%)
Streaming Delayed Price Updated: 1:48 PM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Becton Dickinson

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Monday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
Becton Dickinson BDX Q1 2026 Earnings Transcript ↗
Becton Dickinson BDX Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
Pure-Play Pivot: Decoding Becton Dickinson’s (BDX) Q1 Results and the $17.5B Waters Combination
Today, February 9, 2026, marks a watershed moment for Becton, Dickinson and Company (NYSE: BDX). The medical technology giant, commonly known as BD, has officially closed its transformative $17.5... 
Via Finterra
Topics Artificial Intelligence Economy Product Recall
BECTON DICKINSON AND CO (NYSE:BDX) Beats Q1 FY2026 Estimates but Shares Fall in Pre-Market ↗
Via Chartmill
Becton, Dickinson and Co (NYSE:BDX) Shows High Technical and Setup Ratings for Potential Breakout ↗
Via Chartmill
News headline image
BD (NYSE:BDX) Surprises With Q4 CY2025 Sales
Medical technology company Becton, Dickinson and Company (NYSE:BDX) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 1.6% year on year to $5.25 billion. Its non-GAAP... 
Via StockStory
News headline image
BD Earnings: What To Look For From BDX
Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be reporting results this Monday before the bell. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
1 Cash-Producing Stock to Consider Right Now and 2 We Find Risky
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
News headline image
The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare
The healthcare landscape underwent a seismic shift in 2024, as the industry’s major players pivoted away from traditional hardware toward high-margin diagnostic platforms and artificial intelligence... 
Via MarketMinute
Topics Artificial Intelligence Economy
Friday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
The Great Diagnostic Consolidation: How a $25.7 Billion Mega-Deal Ignited a 150% Surge in Healthcare M&A
As 2026 begins, the healthcare sector is undergoing its most profound transformation in decades. Driven by a relentless push toward "precision medicine" and the industrialization of artificial... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
1 S&P 500 Stock to Own for Decades and 2 We Ignore
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
News headline image
Baxter International (BAX) in 2025: A Deep Dive into the Transformation of a MedTech Giant
As of December 26, 2025, Baxter International Inc. (NYSE: BAX) stands at a pivotal crossroads in its nearly century-long history. Long considered a defensive "blue-chip" staple of the healthcare... 
Via PredictStreet
Topics Economy Emissions Product Recall
News headline image
The Biotech Revolution’s Ultimate ‘Picks and Shovels’ Play: A Deep Dive into West Pharmaceutical Services (WST)
As the pharmaceutical industry undergoes its most significant transformation in decades, the spotlight often falls on the blockbuster drugs themselves—the weight-loss miracles and the life-saving... 
Via MarketMinute
Topics Economy
News headline image
Becton, Dickinson and Co (NYSE:BDX) Shows High Technical and Pattern Scores Ahead of Potential Breakout ↗
BDX stock shows a strong technical uptrend and a high-quality consolidation pattern, signaling a potential breakout opportunity for traders. 
Via Chartmill
News headline image
Which S&P500 stocks are moving on Wednesday? ↗
Let's delve into the developments on the US markets one hour before the close of the markets on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Uncover the latest developments among S&P500 stocks in today's session. ↗
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
3 Reasons BDX is Risky and 1 Stock to Buy Instead
BD trades at $194.13 per share and has stayed right on track with the overall market, gaining 12.5% over the last six months. At the same time, the S&P 500 has returned 14.1%. 
Via StockStory
Topics Stocks
News headline image
Sharps Technology Inc. Warrants Under Scrutiny: Delisting Fears, Digital Pivot, and High-Stakes Investment Potential
Sharps Technology Inc. (NASDAQ: STSS) and its associated Equity Warrants (NASDAQ: STSSW) have become a focal point on investor watchlists, navigating a tumultuous period marked by significant financial... 
Via MarketMinute
Topics Bankruptcy Economy Regulatory Compliance
News headline image
1 Profitable Stock to Own for Decades and 2 We Avoid
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
News headline image
How Do Investors Really Feel About Becton Dickinson & Co? ↗
 
Via Benzinga
News headline image
3 Healthcare Stocks We Approach with Caution
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
News headline image
BD’s Q3 Earnings Call: Our Top 5 Analyst Questions
BD’s third quarter results were broadly in line with Wall Street expectations, reflecting resilience across most of its product portfolio even as certain market headwinds emerged. Management credited... 
Via StockStory
Topics Earnings
News headline image
Unpacking Q3 Earnings: BD (NYSE:BDX) In The Context Of Other Surgical Equipment & Consumables - Diversified Stocks
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - diversified stocks, including BD (NYSE:BDX) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Is the AI Rally a Bubble? Impact on Commodity Demand and Defensive Stock Rotation
As November 2025 unfolds, a subtle yet significant shift in market sentiment is becoming increasingly palpable among financial analysts and retail investors alike. What was once an almost universally... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Got $1,000? Here Are the Smartest Dividend Stocks to Start With. ↗
These eight stocks are a mini portfolio designed for any market drawdown or correction. 
Via The Motley Fool
News headline image
BDX Q3 Deep Dive: Portfolio Resilience and Strategic Actions Amid Macro Headwinds
Medical technology company Becton, Dickinson and Company (NYSE:BDX) met Wall Streets revenue expectations in Q3 CY2025, with sales up 8.3% year on year to $5.89 billion. Its non-GAAP profit of $3.96... 
Via StockStory
News headline image
Becton Dickinson Sees High Single-Digit Profit Growth Ahead, Plans Share Buybacks From Waters Deal ↗
Becton Dickinson posts Q4 earnings beat, raises FY26 EPS outlook, with strong growth in Medical and Interventional segments despite China headwinds. 
Via Benzinga
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.